L'initiation de l'insulinothérapie: une étape difficile à négocier pour les diabétiques de type 2

Insulinotherapy is a necessary transition for many type 2 diabetics and is very difficult to accept for patients and also physicians. Both are resistant to the idea of starting insulin despite many progresses have been done as noted in the French “L&Vous” study. Progresses concern improvement of injection equipment, self-monitoring of blood glucose tools, and basal insulins that are usually recommended for type 2 diabetes. Education programs are often defaulting. A better coordination in health care is absolutly necessary to improve coordinated healthcare circuit.